Detailed kinetics of the direct allo-response in human liver transplant recipients: New insights from an optimized assay

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Tapirdamaz, Özlem ^a   Mancham, Shanta ^a   van der Laan, Luc J W ^a   Kazemier, Geert ^a   Thielemans, Kris ^b   Metselaar, Herold J ^a   Kwekkeboom, Jaap ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD40 ANTIGEN; GAMMA INTERFERON;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; LIVER TRANSPLANTATION; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; SPLEEN CELL; T LYMPHOCYTE; ALLOTRANSPLANTATION; ANIMAL; BIOSYNTHESIS; CELL SEPARATION; CHEMISTRY; CYTOLOGY; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; KINETICS; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; MOUSE; SPLEEN;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; HUMANS; IMMUNOLOGIC TECHNIQUES; INTERFERON-GAMMA; ISOANTIGENS; KINETICS; LEUKOCYTES, MONONUCLEAR; LIVER TRANSPLANTATION; MICE; SPLEEN; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650840504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014452     Document Type: Article

References (58)

1. Smyth LA, Herrera OB, Golshayan D, Lombardi G, Lechler RI (2006) A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Transplantation 82: S15-18.
2. Heeger PS (2003) T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 3: 525-533.
3. Larsen CP, Barker H, Morris PJ, Austyn JM (1990) Failure of mature dendritic cells of the host to migrate from the blood into cardiac or skin allografts. Transplantation 50: 294-301.
4. Saiki T, Ezaki T, Ogawa M, Maeda K, Yagita H, et al. (2001) In vivo roles of donor and host dendritic cells in allogeneic immune response: cluster formation with host proliferating T cells. J Leukoc Biol 69: 705-712.
5. Saiki T, Ezaki T, Ogawa M, Matsuno K (2001) Trafficking of host-and donorderived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 71: 1806-1815.
6. Ueta H, Shi C, Miyanari N, Xu XD, Zhou S, et al. (2008) Systemic transmigration of allosensitizing donor dendritic cells to host secondary lymphoid organs after rat liver transplantation. Hepatology 47: 1352-1362.
7. Bosma BM, Metselaar HJ, Gerrits JH, van Besouw NM, Mancham S, et al. (2010) Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation. Liver Transpl 16: 12-22.
8. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, et al. (2001) Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 167: 7199-7206.
9. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Lechler RI (2001) The role of the allograft in the induction of donor-specific T cell hyporesponsiveness. Transplantation 72: 480-485.
10. Game DS, Hernandez-Fuentes MP, Chaudhry AN, Lechler RI (2003) CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol 14: 1652-1661.
11. Velthuis JH, Mol WM, Weimar W, Baan CC (2006) CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant 6: 2955-2964.
12. de Haan A, van der Gun I, Hepkema BG, de Boer WJ, van der Bij W, et al. (2000) Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: a comparison of lung transplant recipients with or without bronchiolitis obliterans syndrome. Transplantation 69: 1434-1439.
13. de Haan A, van den Berg AP, van der Bij W, Hepkema BG, Bruin-van Dijk E, et al. (2001) Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation. Transplantation 71: 785-791.
14. Lechler RI, Sykes M, Thomson AW, Turka LA (2005) Organ transplantation-how much of the promise has been realized? Nat Med 11: 605-613.
15. Nisbet NW, Simonsen M, Zaleski M (1969) The frequency of antigen-sensitive cells in tissue transplantation. A commentary on clonal selection. J Exp Med 129: 459-467.
16. Atkins RC, Ford WL (1975) Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes. J Exp Med 141: 664-680.
17. Lindahl KF, Wilson DB (1977) Histocompatibility antigen-activated cytotoxic T lymphocytes. I. Estimates of the absolute frequency of killer cells generated in vitro. J Exp Med 145: 500-507.
18. Lindahl KF, Wilson DB (1977) Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J Exp Med 145: 508-522.
19. Matesic D, Lehmann PV, Heeger PS (1998) High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 65: 906-914.
20. Benichou G, Valujskikh A, Heeger PS (1999) Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 162: 352-358.
21. Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, et al. (2001) Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 166: 973-981.
22. van Besouw NM, Zuijderwijk JM, de Kuiper P, Ijzermans JN, Weimar W, et al. (2005) The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation 79: 1062-1066.
23. Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, et al. (2002) Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2: 857-866.
24. McMichael AJ, O'Callaghan CA (1998) A new look at T cells. J Exp Med 187: 1367-1371.
25. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, et al. (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
26. Archbold JK, Macdonald WA, Burrows SR, Rossjohn J, McCluskey J (2008) Tcell allorecognition: a case of mistaken identity or deja vu? Trends Immunol 29: 220-226.
27. Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK (1999) A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230: 99-112.
28. Bercovici N, Givan AL, Waugh MG, Fisher JL, Vernel-Pauillac F, et al. (2003) Multiparameter precursor analysis of T-cell responses to antigen. J Immunol Methods 276: 5-17.
29. Mannering SI, Morris JS, Jensen KP, Purcell AW, Honeyman MC, et al. (2003) A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J Immunol Methods 283: 173-183.
30. Godoy-Ramirez K, Makitalo B, Thorstensson R, Sandstrom E, Biberfeld G, et al. (2005) A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry. Cytometry A 68: 71-80.
31. Schultze JL, Grabbe S, von Bergwelt-Baildon MS (2004) DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy. Trends Immunol 25: 659-664.
32. von Bergwelt-Baildon M, Maecker B, Schultze J, Gribben JG (2004) CD40 activation: potential for specific immunotherapy in B-CLL. Ann Oncol 15: 853-857.
33. von Bergwelt-Baildon M (2007) B cells as a cellular adjuvant: induction or control of T-cell immunity-or both? Expert Rev Vaccines 6: 667-671.
34. Coughlin CM, Vance BA, Grupp SA, Vonderheide RH (2004) RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy. Blood 103: 2046-2054.
35. Stax AM, Gelderman KA, Kamerling SW, van der Geest R, Schlagwein N, et al. (2008) Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo. J Immunol Methods 335: 46-52.
36. Wells AD, Gudmundsdottir H, Turka LA (1997) Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100: 3173-3183.
37. Givan AL, Fisher JL, Waugh MG, Bercovici N, Wallace PK (2004) Use of celltracking dyes to determine proliferation precursor frequencies of antigen-specific T cells. Methods Mol Biol 263: 109-124.
38. Hasbold J, Gett AV, Rush JS, Deenick E, Avery D, et al. (1999) Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol 77: 516-522.
39. de Haan A, van der Gun I, van Dijk E, Hepkema BG, Prop J, et al. (2000) Activation of alloreactive T cells by allogeneic nonprofessional antigenpresenting cells and interleukin-12 from bystander autologous professional antigen-presenting cells. Transplantation 69: 1637-1644.
40. Noorchashm H, Lieu YK, Rostami SY, Song HK, Greeley SA, et al. (1999) A direct method for the calculation of alloreactive CD4+ T cell precursor frequency. Transplantation 67: 1281-1284.
41. Song HK, Noorchashm H, Lieu YK, Rostami S, Greeley SA, et al. (1999) Tracking alloreactive cell division in vivo. Transplantation 68: 297-299.
42. Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, et al. (1997) CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 100: 2757-2765.
43. von Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A, Klein-Gonzalez N, Fiore F, et al. (2006) CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants. Blood 107: 2786-2789.
44. von Bergwelt-Baildon MS, Vonderheide RH, Maecker B, Hirano N, Anderson KS, et al. (2002) Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood 99: 3319-3325.
45. Rodriguez-Pinto D, Moreno J (2005) B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur J Immunol 35: 1097-1105.
46. Dengler TJ, Johnson DR, Pober JS (2001) Human vascular endothelial cells stimulate a lower frequency of alloreactive CD8+ pre-CTL and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes. J Immunol 166: 3846-3854.
47. Macedo C, Orkis EA, Popescu I, Elinoff BD, Zeevi A, et al. (2009) Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant 9: 2057-2066.
48. Lombardi G, Sidhu S, Daly M, Batchelor JR, Makgoba W, et al. (1990) Are primary alloresponses truly primary? Int Immunol 2: 9-13.
49. van Besouw NM, van derMast BJ, de Kuiper P, Smak Gregoor PJ, Vaessen LM, et al. (2000) Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 70: 136-143.
50. van der Mast BJ, van Besouw NM, de Kuiper P, Vaessen LM, Gregoor PJ, et al. (2001) Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation 72: 873-880.
51. Nickel P, Presber F, Bold G, Biti D, Schonemann C, et al. (2004) Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 78: 1640-1646.
52. Nather BJ, Nickel P, Bold G, Presber F, Schonemann C, et al. (2006) Modified ELISPOT technique-highly significant inverse correlation of post-Tx donorreactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. Transpl Immunol 16: 232-237.
53. Bestard O, Nickel P, Cruzado JM, Schoenemann C, Boenisch O, et al. (2008) Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol 19: 1419-1429.
54. Zand MS, Bose A, Vo T, Coppage M, Pellegrin T, et al. (2005) A renewable source of donor cells for repetitive monitoring of T-and B-cell alloreactivity. Am J Transplant 5: 76-86.
55. Brennan TV, Jaigirdar A, Hoang V, Hayden T, Liu FC, et al. (2009) Preferential priming of alloreactive T cells with indirect reactivity. Am J Transplant 9: 709-718.
56. Ng WF, Hernandez-Fuentes M, Baker R, Chaudhry A, Lechler RI (2002) Reversibility with interleukin-2 suggests that T cell anergy contributes to donorspecific hyporesponsiveness in renal transplant patients. J Am Soc Nephrol 13: 2983-2989.
57. De Haan A, Van Der Gun I, Van Der Bij W, De Leij LF, Prop J (2002) Detection of alloreactive T cells by flow cytometry: a new test compared with limiting dilution assay. Transplantation 74: 562-570.
58. Kusaka S, Grailer AP, Fechner JH, Jr., Jankowska-Gan E, Oberley T, et al. (2000) Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient. J Immunol 164: 2240-2247.